Investigating immune responses in a fruit fly model of Alzheimer's disease-related dementia
Mechanism of innate immune activation in a Drosophila model of Alzheimer's disease related dementia
This study is looking at how changes in a gene related to Alzheimer's disease affect the immune system using fruit flies, which could help us find new ways to treat dementia for people like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11020947 on NIH RePORTER |
What this research studies
This research explores how mutations in the GBA gene, which are linked to Alzheimer's disease-related dementia, affect immune responses in a fruit fly model. By creating a fly that lacks the GBA gene, researchers can observe the accumulation of a specific lipid and its impact on neuroinflammation and cognitive decline. The study aims to understand the mechanisms behind these changes and how they relate to the development of dementia. Patients may benefit from insights gained that could lead to new therapeutic strategies for Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a family history of Alzheimer's disease or those carrying GBA gene mutations.
Not a fit: Patients without genetic predispositions to Alzheimer's disease or those with unrelated cognitive impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that target immune responses in Alzheimer's disease-related dementia.
How similar studies have performed: Previous research has shown that investigating genetic mutations related to Alzheimer's can lead to significant advancements in understanding and treating the disease.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Pallanck, Leo J — University of Washington
- Study coordinator: Pallanck, Leo J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.